Holen Sie sich die Stockscreener-App
40.58
6.97%
-3.04
Handel nachbörslich:
40.59
0.01
+0.02%
Überblick
Nachrichten
Preisverlauf
Optionskette
Financials
Forum
Prognose
Aktiensplit
Dividendenhistorie
Schlusskurs vom Vortag:
$43.62
Offen:
$43.42
24-Stunden-Volumen:
1.95M
Relative Volume:
1.62
Marktkapitalisierung:
$2.16B
Einnahmen:
$238.11M
Nettoeinkommen (Verlust:
$-31.45M
KGV:
-64.07
EPS:
-0.6334
Netto-Cashflow:
$7.66M
1W Leistung:
-11.57%
1M Leistung:
-1.84%
6M Leistung:
+21.10%
1J Leistung:
+236.76%
1-Tages-Spanne:
$39.55
$43.65
1-Wochen-Bereich:
$39.55
$46.95
52-Wochen-Spanne:
$11.25
$46.95
Axogen Inc Stock (AXGN) Company Profile
Firmenname
Axogen Inc
Sektor
Branche
Telefon
(386) 462-6817
Adresse
13631 PROGRESS BLVD., ALACHUA, FL
Compare AXGN vs ABT, SYK, MDT, BSX, EW
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
AXGN
Axogen Inc
|
40.58 | 2.16B | 238.11M | -31.45M | 7.66M | -0.6334 |
ABT
Abbott Laboratories
|
93.93 | 163.61B | 45.13B | 6.28B | 7.38B | 3.5895 |
SYK
Stryker Corp
|
329.78 | 126.42B | 25.27B | 3.34B | 4.57B | 8.6334 |
MDT
Medtronic Plc
|
83.87 | 107.36B | 36.36B | 4.84B | 5.43B | 3.7212 |
BSX
Boston Scientific Corp
|
44.77 | 66.54B | 20.62B | 3.56B | 3.48B | 2.3847 |
EW
Edwards Lifesciences Corp
|
92.21 | 53.09B | 6.30B | 1.07B | 1.09B | 1.8406 |
Axogen Inc Stock (AXGN) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2026-02-19 | Eingeleitet | Wells Fargo | Overweight |
| 2025-12-01 | Eingeleitet | Mizuho | Outperform |
| 2025-03-17 | Eingeleitet | Lake Street | Buy |
| 2024-07-01 | Eingeleitet | Raymond James | Outperform |
| 2022-11-11 | Fortgesetzt | Jefferies | Buy |
| 2022-05-09 | Hochstufung | Canaccord Genuity | Hold → Buy |
| 2022-03-11 | Fortgesetzt | Cantor Fitzgerald | Overweight |
| 2020-10-23 | Eingeleitet | Guggenheim | Buy |
| 2020-06-16 | Fortgesetzt | Cantor Fitzgerald | Overweight |
| 2020-05-07 | Herabstufung | Canaccord Genuity | Buy → Hold |
| 2020-04-02 | Herabstufung | BTIG Research | Buy → Neutral |
| 2019-08-07 | Herabstufung | William Blair | Outperform → Mkt Perform |
| 2019-07-12 | Eingeleitet | Canaccord Genuity | Buy |
| 2018-03-02 | Bestätigt | Lake Street | Buy |
| 2018-01-05 | Fortgesetzt | Cantor Fitzgerald | Overweight |
| 2017-11-30 | Eingeleitet | Jefferies | Buy |
| 2017-11-21 | Bestätigt | Lake Street | Buy |
| 2017-07-31 | Eingeleitet | Leerink Partners | Outperform |
| 2017-06-30 | Eingeleitet | Cantor Fitzgerald | Overweight |
| 2017-03-06 | Eingeleitet | ROTH Capital | Buy |
| 2016-11-22 | Hochstufung | Lake Street | Hold → Buy |
| 2016-11-07 | Bestätigt | Wedbush | Outperform |
| 2016-11-03 | Herabstufung | Lake Street | Buy → Hold |
| 2016-08-04 | Bestätigt | Wedbush | Outperform |
| 2014-05-14 | Eingeleitet | Dawson James | Buy |
| 2013-10-31 | Bestätigt | Ladenburg Thalmann | Buy |
Alle ansehen
Axogen Inc Aktie (AXGN) Neueste Nachrichten
What Axogen (AXGN)'s Russell Index Removal Means For Shareholders - simplywall.st
AXGN Q1 2026 Earnings: EPS Misses Estimates as Stock DeclinesNew Analyst Coverage - dars.gov.et
Axogen stock hits 52-week high at 46.05 USD - Investing.com UK
Axogen stock hits 52-week high at 46.05 USD By Investing.com - Investing.com Nigeria
Will Axogen’s (AXGN) Russell Index Removal Reshape Its Liquidity Profile and Risk‑Reward Narrative? - Sahm
Axogen, Inc.(NasdaqCM: AXGN) dropped from Russell 3000E Index - marketscreener.com
Axogen, Inc.(NasdaqCM: AXGN) dropped from Russell Microcap Index - marketscreener.com
Axogen, Inc.(NasdaqCM: AXGN) dropped from Russell 3000E Growth Benchmark - marketscreener.com
Price to earnings forward of Axogen, Inc. – NASDAQ:AXGN - TradingView
Daily Brief Health Care: AxoGen Inc, Dentsply International and more - Smartkarma
Form 4 Axogen Inc For: 26 June By Investing.com - Investing.com Nigeria
AXGN News | AXOGEN INC (NASDAQ:AXGN) - ChartMill
Axogen (AXGN) director receives 4,392 restricted stock units in annual equity grant - Stock Titan
Axogen (AXGN) director Alan Levine granted 4,392 RSUs valued at $185K - Stock Titan
Axogen (AXGN) director receives 4,392 RSUs in $185,000 equity grant - Stock Titan
Axogen (AXGN) director Wendell McBride awarded 4,392 RSUs valued at $185,000 - Stock Titan
Q4 2025 AxoGen Inc Earnings Call Transcript - GuruFocus
Q1 2025 AxoGen Inc Earnings Call Transcript - GuruFocus
Form DEF 14A Axogen Inc For: 25 June By Investing.com - Investing.com Nigeria
Price to earnings forward of Axogen, Inc. – FWB:LT3 - TradingView
Axogen, Inc. Actuals & Estimates (NASDAQ:AXGN) - TradingView
Enterprise value to revenue forward of Axogen, Inc. – NASDAQ:AXGN - TradingView
AXGN Forecast — Price Target — Prediction for 2027 - TradingView
Enterprise value to EBIT forward of Axogen, Inc. – NASDAQ:AXGN - TradingView
Enterprise value to EBITDA forward of Axogen, Inc. – NASDAQ:AXGN - TradingView
Price to sales forward of Axogen, Inc. – FWB:LT3 - TradingView
Price to book forward of Axogen, Inc. – NASDAQ:AXGN - TradingView
Responsive Playbooks and the AXGN Inflection - Stock Traders Daily
Form 4 Axogen Inc For: 23 June By Investing.com - Investing.com India
Form 8K Axogen Inc For: 23 June By Investing.com - Investing.com India
Axogen shareholders elect board members and approve auditor at annual meeting By Investing.com - Investing.com South Africa
Axogen shareholders elect board members and approve auditor at annual meeting - Investing.com Australia
Axogen (AXGN) investors approve directors, auditor and executive pay at 2026 meeting - Stock Titan
Axogen (NASDAQ: AXGN) director receives 14,150 shares from $150K RSU grant - Stock Titan
Axogen (AXGN) director Alan Levine receives 14,150 shares from vested RSU grant - Stock Titan
Axogen (AXGN) director receives 14,150 shares as $150,000 RSU grant vests - Stock Titan
Axogen (AXGN) director gains 18,867 common shares from RSU vesting - Stock Titan
Axogen (AXGN) director gains 14,150 shares from RSU vesting - Stock Titan
Axogen (AXGN) director gains 14,150 common shares from RSU vesting - Stock Titan
Axogen (AXGN) director Burke receives 14,150 shares from vested RSU grant - Stock Titan
AxoGen Inc Annual Shareholders Meeting Transcript - GuruFocus
Finanzdaten der Axogen Inc-Aktie (AXGN)
Umsatz
Nettogewinn
Free Cashflow
ENV
2.36%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):